ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $166,000 | -12.2% | 1,785 | -43.8% | 0.06% | -24.1% |
| Q3 2021 | $189,000 | -17.1% | 3,178 | -5.1% | 0.08% | -11.7% |
| Q2 2021 | $228,000 | -23.2% | 3,350 | -21.6% | 0.09% | -24.8% |
| Q1 2021 | $297,000 | -8.0% | 4,273 | +1.7% | 0.12% | -6.7% |
| Q4 2020 | $323,000 | -14.1% | 4,202 | -16.5% | 0.13% | -32.0% |
| Q3 2020 | $376,000 | +4.7% | 5,034 | -11.8% | 0.20% | +15.9% |
| Q2 2020 | $359,000 | +11.8% | 5,707 | -25.4% | 0.17% | +28.8% |
| Q1 2020 | $321,000 | -19.3% | 7,650 | -12.7% | 0.13% | +103.1% |
| Q4 2019 | $398,000 | +89.5% | 8,758 | +91.1% | 0.06% | +54.8% |
| Q3 2019 | $210,000 | -26.1% | 4,584 | -5.3% | 0.04% | -30.0% |
| Q2 2019 | $284,000 | – | 4,838 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |